 Effective treatment small-noncleaved-cell lymphoma high-intensity brief-duration chemotherapy Small-noncleaved-cell SNC lymphoma high-grade aggressive neoplasm notable poor response high relapse rate long-term survival patients SNC lymphoma novel chemotherapeutic regimen intensive doses chemotherapy frequent intervals inpatient setting patients Sixteen patients stage IV disease patients characteristic poor prognosis bulky cm disease multiple extranodal sites poor performance status characteristics poor prognosis Seventeen patients complete response CR patients human immunodeficiency virus HIV disease relapses months treatment relapses patients unable therapy median follow-up months patients disease-free calculated actuarial disease-free survival Toxicity chiefly myelosuppression severe manageable treatment-related deaths elderly patients poor performance status advanced-stage disease data dose-intensive approach response survival patients SNC lymphoma